US Bancorp’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-807,593
| Closed | -$80.2M | – | 3838 |
|
|
2019
Q3 | $80.2M | Sell |
807,593
-22,544
| -3% | -$2.14M | 0.22% | 103 |
|
|
2019
Q2 | $76.7M | Sell |
830,137
-6,635
| -0.8% | -$630K | 0.21% | 106 |
|
|
2019
Q1 | $78.9M | Sell |
836,772
-87,119
| -9% | -$7.62M | 0.23% | 100 |
|
|
2018
Q4 | $59.2M | Sell |
923,891
-130,472
| -12% | -$9.63M | 0.19% | 115 |
|
|
2018
Q3 | $94.4M | Buy |
1,054,363
+74,017
| +8% | +$6.54M | 0.27% | 91 |
|
|
2018
Q2 | $77.9M | Buy |
980,346
+150,932
| +18% | +$12.5M | 0.24% | 99 |
|
|
2018
Q1 | $74M | Buy |
829,414
+57,907
| +8% | +$5.56M | 0.23% | 103 |
|
|
2017
Q4 | $80.5M | Sell |
771,507
-25,580
| -3% | -$2.89M | 0.25% | 99 |
|
|
2017
Q3 | $116M | Buy |
797,087
+33,786
| +4% | +$4.6M | 0.37% | 70 |
|
|
2017
Q2 | $99.1M | Buy |
763,301
+48,085
| +7% | +$5.89M | 0.33% | 79 |
|
|
2017
Q1 | $89M | Buy |
715,216
+37,668
| +6% | +$4.51M | 0.3% | 85 |
|
|
2016
Q4 | $78.4M | Buy |
677,548
+17,002
| +3% | +$1.89M | 0.28% | 88 |
|
|
2016
Q3 | $69M | Sell |
660,546
-2,252
| -0.3% | -$244K | 0.26% | 98 |
|
|
2016
Q2 | $65.4M | Buy |
662,798
+53,072
| +9% | +$5.49M | 0.25% | 97 |
|
|
2016
Q1 | $61M | Buy |
609,726
+89,720
| +17% | +$9.24M | 0.24% | 98 |
|
|
2015
Q4 | $62.3M | Buy |
520,006
+24,384
| +5% | +$2.82M | 0.25% | 97 |
|
|
2015
Q3 | $53.6M | Buy |
495,622
+67,101
| +16% | +$8.33M | 0.22% | 101 |
|
|
2015
Q2 | $49.6M | Buy |
428,521
+6,239
| +1% | +$713K | 0.19% | 117 |
|
|
2015
Q1 | $48.7M | Buy |
422,282
+14,539
| +4% | +$1.74M | 0.19% | 115 |
|
|
2014
Q4 | $45.6M | Buy |
407,743
+8,240
| +2% | +$869K | 0.18% | 122 |
|
|
2014
Q3 | $37.9M | Sell |
399,503
-29,553
| -7% | -$2.67M | 0.15% | 131 |
|
|
2014
Q2 | $36.8M | Buy |
429,056
+17,576
| +4% | +$1.34M | 0.15% | 133 |
|
|
2014
Q1 | $28.7M | Sell |
411,480
-4,802
| -1% | -$380K | 0.12% | 153 |
|
|
2013
Q4 | $35.2M | Buy |
416,282
+7,572
| +2% | +$599K | 0.14% | 134 |
|
|
2013
Q3 | $31.5M | Sell |
408,710
-12,784
| -3% | -$896K | 0.14% | 137 |
|
|
2013
Q2 | $24.7M | Buy |
+421,494
| New | +$25.4M | 0.11% | 151 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
US Bancorp's CELG Position: Q4 2019 in Review
US Bancorp sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 807,593 shares — an estimated $80.2M sold.
US Bancorp first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $116M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- US Bancorp reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- US Bancorp sold 807,593 Celgene Corp shares in Q4 2019, an estimated $80.2M.
- US Bancorp first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- US Bancorp's Celgene Corp position peaked at $116M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.